Walmart’s sharp decline highlights growing concern over U.S. consumer resilience, as slower comparable-sales growth and …
Walmart’s sharp decline highlights growing concern over U.S. consumer resilience, as slower comparable-sales growth and reliance on a one-off tariff refund weakened the quality of its earnings beat. Moderna’s reversal reflects profit-taking after its historic 177% rally, rather than necessarily a change in the underlying cancer-treatment outlook. Meanwhile, rising Treasury yields pressured equities broadly, reinforcing a more cautious risk environment.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.